Please login to the form below

Not currently logged in
Email:
Password:

Microsoft creates ‘Emma’ to aid with Parkinson’s

Prototype watch reduces uncontrollable shaking

Project Emma

Microsoft has unveiled a prototype watch named ‘Project Emma’ for people suffering with Parkinson’s disease.

The tech firm’s wearable is designed to reduce uncontrollable shaking that’s brought on by the progressive deterioration of nerve cells in the brain.

It does this through small vibration motors inside the watch that stops the brain from creating as many tremors.

Haiyan Zheg, innovation director at Microsoft Research Cambridge, explained: “I’ve been chatting with Emma [a friend and graphic designer with Parkinson’s], researchers and experts to put together a deeper piece of research on how AI and wearables can better support people with Parkinson’s to manage their symptoms and medication intake.”

“This would be an extension of the original Emma Watch project but could be quite an impactful piece of work, however, it’s still only in the proposal stage.”

The watch was introduced at Microsoft Build conference in Seattle and the company will start initial trials of the device in London.

Article by
Gemma Jones

13th June 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics